Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulin-producing cells.
Lortz S, Tiedge M. Lortz S, et al. Free Radic Biol Med. 2003 Mar 15;34(6):683-8. doi: 10.1016/s0891-5849(02)01371-0. Free Radic Biol Med. 2003. PMID: 12633745
Effect of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats.
Lenzen S, Lortz S, Tiedge M. Lenzen S, et al. Among authors: lortz s. Biochem Pharmacol. 1996 Apr 12;51(7):893-6. doi: 10.1016/0006-2952(95)02243-0. Biochem Pharmacol. 1996. PMID: 8651938
Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells.
Tiedge M, Lortz S, Drinkgern J, Lenzen S. Tiedge M, et al. Among authors: lortz s. Diabetes. 1997 Nov;46(11):1733-42. doi: 10.2337/diab.46.11.1733. Diabetes. 1997. PMID: 9356019
Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
Tiedge M, Lortz S, Munday R, Lenzen S. Tiedge M, et al. Among authors: lortz s. Diabetes. 1998 Oct;47(10):1578-85. doi: 10.2337/diabetes.47.10.1578. Diabetes. 1998. PMID: 9753295
Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells.
Tiedge M, Lortz S, Munday R, Lenzen S. Tiedge M, et al. Among authors: lortz s. Diabetologia. 1999 Jul;42(7):849-55. doi: 10.1007/s001250051237. Diabetologia. 1999. PMID: 10440128
Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes.
Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S. Lortz S, et al. Diabetes. 2000 Jul;49(7):1123-30. doi: 10.2337/diabetes.49.7.1123. Diabetes. 2000. PMID: 10909968
The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus.
Lenzen S, Tiedge M, Elsner M, Lortz S, Weiss H, Jörns A, Klöppel G, Wedekind D, Prokop CM, Hedrich HJ. Lenzen S, et al. Among authors: lortz s. Diabetologia. 2001 Sep;44(9):1189-96. doi: 10.1007/s001250100625. Diabetologia. 2001. PMID: 11596676
Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells.
Azevedo-Martins AK, Lortz S, Lenzen S, Curi R, Eizirik DL, Tiedge M. Azevedo-Martins AK, et al. Among authors: lortz s. Diabetes. 2003 Jan;52(1):93-101. doi: 10.2337/diabetes.52.1.93. Diabetes. 2003. PMID: 12502498
Cytokines and nitric oxide inhibit the enzyme activity of catalase but not its protein or mRNA expression in insulin-producing cells.
Sigfrid LA, Cunningham JM, Beeharry N, Lortz S, Tiedge M, Lenzen S, Carlsson C, Green IC. Sigfrid LA, et al. Among authors: lortz s. J Mol Endocrinol. 2003 Dec;31(3):509-18. doi: 10.1677/jme.0.0310509. J Mol Endocrinol. 2003. PMID: 14664711
Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines.
Gurgul E, Lortz S, Tiedge M, Jörns A, Lenzen S. Gurgul E, et al. Among authors: lortz s. Diabetes. 2004 Sep;53(9):2271-80. doi: 10.2337/diabetes.53.9.2271. Diabetes. 2004. PMID: 15331536
30 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback